Janney Montgomery Scott’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Janney Montgomery Scott’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,449	Closed	-$677K	–	2768
2024 Q1	$677K	Buy	+8,449	New	+$655K	﹤0.01%	1754
2016 Q1	–	Sell	-6,019	Closed	-$421K	–	1380
2015 Q4	$421K	Sell	6,019 -1,554	-21%	-$110K	0.01%	897
2015 Q3	$502K	Sell	7,573 -975	-11%	-$75.9K	0.01%	831
2015 Q2	$670K	Buy	8,548 +458	+6%	+$35.7K	0.01%	999
2015 Q1	$618K	Buy	8,090 +2,496	+45%	+$183K	0.01%	1203
2014 Q4	$372K	Buy	5,594 +211	+4%	+$14.1K	0.01%	1524
2014 Q3	$343K	Buy	5,383 +252	+5%	+$15.6K	0.01%	1544
2014 Q2	$313K	Buy	5,131 +409	+9%	+$23.7K	0.01%	1587
2014 Q1	$268K	Sell	4,722 -38	-0.8%	-$2.16K	0.01%	1534
2013 Q4	$255K	Sell	4,760 -188	-4%	-$9.41K	0.01%	1543
2013 Q3	$228K	Buy	+4,948	New	+$226K	0.01%	1557

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Janney Montgomery Scott's PJP Position: Q2 2024 in Review

Janney Montgomery Scott sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2024, closing a stake of 8,449 shares — an estimated $677K sold.

Janney Montgomery Scott first reported a position in PJP in Q3 2013 and held it in 11 quarters. The position peaked at $677K in Q1 2024. 89 funds tracked by Wall St. Rank hold PJP as of Q2 2024.

Janney Montgomery Scott reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
Janney Montgomery Scott sold 8,449 Invesco Pharmaceuticals ETF shares in Q2 2024, an estimated $677K.
Janney Montgomery Scott first reported a position in Invesco Pharmaceuticals ETF in Q3 2013 and held it in 11 quarters.
Janney Montgomery Scott's Invesco Pharmaceuticals ETF position peaked at $677K in Q1 2024.
89 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2024.

Based on Janney Montgomery Scott's 13F filing for Q2 2024, filed 25 Jul 2024.